Increasing understanding of the mechanisms underpinning immune-mediated inflammatory diseases such as psoriasis, Crohn's disease (CD) and ankylosing spondylitis (AS) has implicated a pivotal role for the IL-23/Th17 cells axis in their pathogenesis [1], [2], [3], [4]. Here, IL23A is linked to psoriasis.